Bolt Biotherapeutics Inc (BOLT) Stock Price, Quote, News & History

BOLTNASDAQ
$3.46
-0.10-2.81%
Last update: Sep 21, 12:33 PM

Bolt Biotherapeutics (BOLT) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-31.45M
Investing Cash Flow (TTM)
34.65M
Financing Cash Flow (TTM)
30.00K
Free Cash Flow (TTM)
-31.54M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
3.23M

Analyst Trends and Forecast

2
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$11.00M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
1.35
PB Ratio (TTM)
0.55
Earnings Yield % (TTM)
-456.08%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$6.56

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$12.86M
Debt to Equity
1.71
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$3.47
Close
-
Volume / Avg.
17.09K / 28.45K
Day Range
$3.38 - $3.56
52 Wk Range
3.10 - 7.20
Market Cap
$6.67M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
0.81%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs in...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Bolt Biotherapeutics (BOLT) stock?

A

You can purchase shares of Bolt Biotherapeutics (NASDAQ:BOLT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Bolt Biotherapeutics (BOLT) competitors?

Q

What is the forecast, or price target, for Bolt Biotherapeutics (BOLT) stock?

A

Bolt Biotherapeutics has a consensus price target of $28.80.

Q

What is the current price for Bolt Biotherapeutics (BOLT)?

A

The stock price for Bolt Biotherapeutics (NASDAQ: BOLT) is $3.46 last updated September 21, 2026 at 12:33 PM EDT.

Q

Does Bolt Biotherapeutics (BOLT) pay a dividend?

A

There are no upcoming dividends for Bolt Biotherapeutics.

Q

When is Bolt Biotherapeutics (NASDAQ:BOLT) reporting earnings?

A

Bolt Biotherapeutics does not have any upcoming earnings scheduled.

Q

Is Bolt Biotherapeutics (BOLT) going to split?

A

There is no upcoming split for Bolt Biotherapeutics.

Q

What sector and industry does Bolt Biotherapeutics (BOLT) operate in?

A

Bolt Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.